White Papers

PRA Whitepaper: Sponsor & CRO Pharmacovigilance Alliances – Best Practices to Ensure Success

On a global basis, contract research revenues reached an estimated $21.6bn in 2009, having expanded by more than 10% per year since the mid 1990s. Over the next five years, contract research spending is expected to continue its strong growth, with total revenues rising by 9.9% per year to reach $34.6bn by 2014. While estimates of outsourcing satisfaction vary, it is not uncommon for as many as 35% - 55% of sponsors to report moderate to significant dissatisfaction with a project; according to the report “The Future of R&D Outsourcing” published in 2010 by Business Insights. The best relationships between sponsors and contractors are those that are well defined from the outset. This whitepaper outlines the best practices to ensure success when outsourcing pharmacovigilance services.